Blood

Mild hemophilia B

ORPHA:169799 ↗Gene F9Clinical subtype

Search all Mild hemophilia B trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No recruiting trial found right now.

4 studies are registered for Mild hemophilia B, but none was recruiting as of 7 Sept 2026. Here is what is still worth doing.

Alert me when one opens Check expanded access Trials not yet recruiting Recently completed studies Find patient organisations Specialist centres and registries

Keep watching

Get an email when a new Mild hemophilia B study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:169799 ↗

About Mild hemophilia B

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (F9).

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

13 approved treatments and 9 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Coagulation Factor Ix Human (Coagulation factor ix human component of balfaxar)Approved: Characterised Viable Autologous Cartilage Cells Expanded Ex Vivo Expressing Specific Marker Proteins (Chondrocelect)Approved: Albutrepenonacog Alfa (Idelvion)Approved: Nonacog Beta Pegol (Refixia)Approved: Etranacogene Dezaparvovec (Hemgenix)Approved: Coagulation Factor Ix Recombinant Human (Benefix)Approved: Eptacog Beta (Activated) (Cevenfacta)Approved: Concizumab (Alhemo)Approved: Spheroids Of Human Autologous Matrix-Associated Chondrocytes (Spherox)Approved: Eftrenonacog Alfa (Alprolix)Approved: Eptacog Alfa (Activated) (Novoseven)Approved: Fidanacogene Elaparvovec (Beqvez)Approved: Marstacimab (Hympavzi)

Phase 3Anti-Inhibitor Coagulant Complex

Phase 3Trenonacog Alfa (Ixinity[tm])

Phase 3Vatreptacog Alfa (Activated)

Phase 3Fitusiran

Phase 2Bay-1093884

Phase 2Eptacog Alfa Pegol (Activated)

Phase 2Ataluren (Translarna)

Phase 1/2Verbrinacogene Setparvovec

+ 1 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).